Intellia Therapeutics Inc (NTLA)
14.50
-0.16
(-1.06%)
USD |
NASDAQ |
Dec 04, 16:00
14.49
0.00 (0.00%)
After-Hours: 20:00
Intellia Therapeutics Profit Margin (Quarterly): -1.49K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.49K% |
| June 30, 2024 | -2.11K% |
| March 31, 2024 | -371.3% |
| December 31, 2023 | |
| September 30, 2023 | -1.02K% |
| June 30, 2023 | -909.8% |
| March 31, 2023 | -818.1% |
| December 31, 2022 | -835.5% |
| September 30, 2022 | -853.5% |
| June 30, 2022 | -717.6% |
| March 31, 2022 | -1.31K% |
| December 31, 2021 | -632.0% |
| September 30, 2021 | -994.5% |
| June 30, 2021 | -1.05K% |
| March 31, 2021 | -716.9% |
| December 31, 2020 | -639.8% |
| September 30, 2020 | -125.3% |
| June 30, 2020 | -199.2% |
| March 31, 2020 | -246.3% |
| December 31, 2019 | -258.6% |
| Date | Value |
|---|---|
| September 30, 2019 | -222.6% |
| June 30, 2019 | -231.0% |
| March 31, 2019 | -210.3% |
| December 31, 2018 | -242.0% |
| September 30, 2018 | -306.5% |
| June 30, 2018 | -289.4% |
| March 31, 2018 | -285.9% |
| December 31, 2017 | -359.4% |
| September 30, 2017 | -209.9% |
| June 30, 2017 | -263.5% |
| March 31, 2017 | -203.2% |
| December 31, 2016 | -187.7% |
| September 30, 2016 | -153.7% |
| June 30, 2016 | -164.1% |
| March 31, 2016 | -376.4% |
| December 31, 2015 | -309.8% |
| September 30, 2015 | -178.9% |
| June 30, 2015 | -220.8% |
| March 31, 2015 | -84.99% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.11K%
Minimum
Jun 2024
-125.3%
Maximum
Sep 2020
-805.0%
Average
-818.1%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| BridgeBio Pharma Inc | -5.93K% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Ionis Pharmaceuticals Inc | -105.0% |
| Pfizer Inc | 25.22% |
| Regeneron Pharmaceuticals Inc | 36.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.64% |
| Return on Assets | -42.33% |
| Return on Invested Capital | -51.64% |
| Operating Margin (Quarterly) | -1.59K% |
| Return on Net Operating Assets | -323.0% |